Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Carls-Bergh Pharma AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 2,373 Less Arrow 1,924 More Arrow 2,007
Financial expenses 0 More Arrow 2 More Arrow 4
Earnings before taxes -83 Less Arrow -93 More Arrow 14
EBITDA -59 Less Arrow -66 More Arrow 53
Total assets 2,506 Less Arrow 2,352 Less Arrow 2,244
Current assets 1,533 Less Arrow 1,328 Less Arrow 1,205
Current liabilities 569 More Arrow 601 Less Arrow 387
Equity capital 1,424 More Arrow 1,467 Less Arrow 1,457
- share capital 17 More Arrow 18 Equal arrow 18
Employees (average) 13 Less Arrow 12 More Arrow 14

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 56.8% More Arrow 62.4% More Arrow 64.9%
Turnover per employee 183 Less Arrow 160 Less Arrow 143
Profit as a percentage of turnover -3.5% Less Arrow -4.8% More Arrow 0.7%
Return on assets (ROA) -3.3% Less Arrow -3.9% More Arrow 0.8%
Current ratio 269.4% Less Arrow 221.0% More Arrow 311.4%
Return on equity (ROE) -5.8% Less Arrow -6.3% More Arrow 1.0%
Change turnover 514 Less Arrow -89 Less Arrow -251
Change turnover % 28% Less Arrow -4% Less Arrow -11%
Chg. No. of employees 1 Less Arrow -2 More Arrow 0
Chg. No. of employees % 8% Less Arrow -14% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.